The Dementia Symptom Management at Home Program Hospice Edition
NCT ID: NCT03352791
Last Updated: 2019-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2018-08-01
2018-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dementia Symptom Management at Home Program
NCT03255967
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial
NCT03681119
The Dementia Symptom Management at Home Program
NCT02482623
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)
NCT04175977
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
NCT07182357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DSM-H Hospice Edition
training, assigning of champions to serve as mentors and performance improvement leads, and workflow changes including caregiver education pamphlets, interdisciplinary care plans, treatment algorithms, and assessment instruments.
DSM-H Hospice Edition performance improvement program
Patients in the performance improvement group will receive care from a care team who has received the DSM-H Hospice Edition performance improvement program
Control Arm
Usual Care
Usual Care
control will receive usual care from a care team who has not received the performance improvement program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DSM-H Hospice Edition performance improvement program
Patients in the performance improvement group will receive care from a care team who has received the DSM-H Hospice Edition performance improvement program
Usual Care
control will receive usual care from a care team who has not received the performance improvement program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to MJHS hospice agency
* The patient and family caregiver speak English and/or Spanish.
* The informal caregiver is ≥18 years of age and spends at least 8 hours per week with the patient.
* Patients who score ≥6 on the Quick Dementia Rating Scale (at least mild impairment).
Exclusion Criteria
* PWD residing in assisted living facilities, nursing homes or board and care homes
* PWD solely receiving infusion or home health aide services.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abraham Brody, PhD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-01080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.